Extension Study of MYL-1701P-3001 for Safety and Efficacy

Clinical trial NCT04674800 · COMPLETED

Trial details

NCT number: NCT04674800
Sponsor: Mylan Pharmaceuticals Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema

Start date: 2020-11-23
Primary completion: 2022-04-20
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.